Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer

Mol Immunol. 2022 Apr:144:117-126. doi: 10.1016/j.molimm.2022.02.005. Epub 2022 Feb 23.

Abstract

Id3, an inhibitor of DNA binding protein, plays important roles in the function and homeostasis of effector and memory T cells. Recent evidence has shown that Id3 is also implicated in CD8 T cell exhaustion. However, whether and how Id3 might regulate effector function or exhaustion of CD8 T cells, especially in the tumor setting, is still unknown. Here, we first showed that Id3 expression was impaired in tumor-infiltrating CD8 T cells as liver cancer progressed, especially in PD-1 +Tim-3 + exhausted CD8 T cells. Enforced expression of Id3 in CD8 T cells resulted in repressed development of anti-tumor CTLs exhaustion, which offered better tumor control. And partially depletion of Id3 in CD8 T cells promoted the development of exhausted CD8 T cells. Furthermore, Id3hi CD8 T cells could respond to PD-1 blockade. Collectively, Id3 exerts protective functions in CD8 T cells for liver cancer.

Keywords: CD8 exhaustion; Id3; Liver cancer; PD-1 blockade.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes / metabolism
  • Humans
  • Inhibitor of Differentiation Proteins / genetics
  • Inhibitor of Differentiation Proteins / metabolism
  • Liver Neoplasms* / metabolism
  • Neoplasm Proteins / metabolism
  • Programmed Cell Death 1 Receptor* / metabolism

Substances

  • Inhibitor of Differentiation Proteins
  • Neoplasm Proteins
  • Programmed Cell Death 1 Receptor
  • ID3 protein, human